Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Procter & Gamble
PG
|
+$1.21B |
| 2 |
FedEx
FDX
|
+$1.08B |
| 3 |
JPMorgan Chase
JPM
|
+$1.01B |
| 4 |
McDonald's
MCD
|
+$852M |
| 5 |
Humana
HUM
|
+$835M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.29B |
| 2 |
Intel
INTC
|
+$1.38B |
| 3 |
Bank of America
BAC
|
+$1.14B |
| 4 |
Verizon
VZ
|
+$1.1B |
| 5 |
Netflix
NFLX
|
+$1.07B |
Sector Composition
| 1 | Healthcare | 23.14% |
| 2 | Technology | 18.46% |
| 3 | Financials | 11.78% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Pacira BioSciences
PCRX
$1.2B
| $22.5M | ﹤0.01% |
373,654
-856
| -0.2% | -$51.5K |
|
927
Cohu
COHU
$976M
| $22.4M | ﹤0.01% |
1,302,619
-121,301
| -9% | -$2.08M |
|
928
NetEase
NTES
$92.3B
| $22.3M | ﹤0.01% |
245,410
-257,675
| -51% | -$23.4M |
|
929
Atlanta Braves Holdings Series B
BATRK
$2.62B
| $22.3M | ﹤0.01% |
1,061,751
+393,886
| +59% | +$8.28M |
|
|
RDS.B
930
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $22.3M | ﹤0.01% |
919,820
+846,977
| +1,163% | +$20.5M |
|
931
Interpublic Group of Companies
IPG
$9.51B
| $22.2M | ﹤0.01% |
1,332,525
+134,068
| +11% | +$2.23M |
|
932
KKR & Co
KKR
$124B
| $22.1M | ﹤0.01% |
+644,165
| New | +$22.1M |
|
933
AT&T
T
$209B
| $22M | ﹤0.01% |
1,021,925
-386,190
| -27% | -$8.32M |
|
|
CDK
934
DELISTED
CDK Global, Inc.
CDK
| $21.9M | ﹤0.01% |
502,249
-188,171
| -27% | -$8.2M |
|
935
Infosys
INFY
$70.4B
| $21.8M | ﹤0.01% |
1,580,568
-68,892
| -4% | -$951K |
|
936
Caesars Entertainment
CZR
$5.33B
| $21.6M | ﹤0.01% |
+385,770
| New | +$21.6M |
|
|
CTXS
937
DELISTED
Citrix Systems Inc
CTXS
| $21.5M | ﹤0.01% |
156,480
-449
| -0.3% | -$61.8K |
|
938
AtriCure
ATRC
$1.75B
| $21.4M | ﹤0.01% |
536,571
-41,989
| -7% | -$1.68M |
|
939
Iovance Biotherapeutics
IOVA
$861M
| $21.3M | ﹤0.01% |
647,310
-2,122
| -0.3% | -$69.9K |
|
|
TREC
940
DELISTED
Trecora Resources
TREC
| $21.2M | ﹤0.01% |
3,460,097
| – | – |
|
941
DMC Global
BOOM
$141M
| $21.1M | ﹤0.01% |
640,876
-25,800
| -4% | -$850K |
|
942
Avidity Biosciences
RNA
$5.97B
| $21.1M | ﹤0.01% |
748,107
-126,981
| -15% | -$3.57M |
|
943
Outfront Media
OUT
$3.12B
| $20.9M | ﹤0.01% |
1,457,402
+1,173,845
| +414% | +$16.8M |
|
|
LEAP.U
944
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
| $20.8M | ﹤0.01% |
+1,600,919
| New | +$20.8M |
|
945
Assembly Biosciences
ASMB
$171M
| $20.8M | ﹤0.01% |
105,477
-11,175
| -10% | -$2.2M |
|
|
CSII
946
DELISTED
Cardiovascular Systems, Inc.
CSII
| $20.8M | ﹤0.01% |
527,353
-485,971
| -48% | -$19.1M |
|
947
iShares MSCI EAFE Small-Cap ETF
SCZ
$10.8B
| $20.6M | ﹤0.01% |
350,008
+222,342
| +174% | +$13.1M |
|
948
Liberty Media Series C
FWONK
$24.7B
| $20.1M | ﹤0.01% |
572,700
-472
| -0.1% | -$16.6K |
|
949
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
| $20M | ﹤0.01% |
313,285
-48,215
| -13% | -$3.07M |
|
950
Akebia Therapeutics
AKBA
$777M
| $19.9M | ﹤0.01% |
7,924,972
+650,249
| +9% | +$1.63M |
|